Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Nanette F Santoro, MD
Advertisement
Articles by Nanette F Santoro, MD
The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.
Advertisement
Latest Updated Articles
Women’s Health Takeaways for Primary Care: Expert Insights From ACOG 2025Published: June 6th 2025 | Updated:
Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program TrialsPublished: May 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Deep Transcranial Magnetic Stimulation Device for MDD Treatment in Youth Ages 15 to 21, BrainsWay Announces
2
Autoimmune Disease Risk After HT: Clinical Insights From a Large Real-World Study
3
For GLP-1 Medication Users, Investigational NK-1 Agent May Quell GI Side Effects by Half
4
Reinterpreting WHI and Rethinking GSM: Insights from Caroline Mitchell, MD, MPH
5
